Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration Ren-Ching WangL. Jeffrey MedeirosKung-Chao Chang Images in Hematology 05 December 2018 Pages: 133 - 134
Lead poisoning as final diagnosis in a study of normocytic anemia Valle RecasensAngeles MontañésEduardo Bustamante Images in Hematology 06 December 2018 Pages: 135 - 136
JSH practical guidelines for hematological malignancies, 2018: 7. Peripheral T-cell lymphoma (PTCL) Motoko YamaguchiRitsuro Suzuki Guide Line 22 January 2019 Pages: 137 - 140
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies Daisuke MinakataShin-ichiro FujiwaraYoshinobu Kanda Original Article 08 December 2018 Pages: 141 - 146
Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute Junichiro TakanoSohtaro MineShotaro Hagiwara Original Article 16 October 2018 Pages: 147 - 153
Characteristics and prognosis of patients with non-immunoglobulin-M monoclonal gammopathy of undetermined significance: a retrospective study chihiro KuwabaraYukie SakumaHiroaki Tanaka Original Article 08 November 2018 Pages: 154 - 161
Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia Takayoshi TachibanaSatoshi KoyamaHeiwa Kanamori Original Article 03 December 2018 Pages: 162 - 168
Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation Wen GaoJie LiWenming Chen Original Article 11 October 2018 Pages: 169 - 174
Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma Satoshi YamasakiDai ChiharaRitsuro Suzuki Original Article 14 November 2018 Pages: 175 - 186
Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population Ting-An LinChing-Fen YangJyh-Pyng Gau Original Article 13 December 2018 Pages: 187 - 196
Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation Tomoaki UedaTetsuo MaedaYuzuru Kanakura Original Article 17 November 2018 Pages: 197 - 205
Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan Ryu YanagisawaYozo NakazawaHLH/LCH committee members of the Japan Children’s Cancer Group Original Article 07 December 2018 Pages: 206 - 213
A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis Hina OgawaMasayoshi SouriAkitada Ichinose Case Report 16 November 2018 Pages: 214 - 220
Epstein–Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution Kazuharu KamachiTakero ShindoShinya Kimura Case Report 27 October 2018 Pages: 221 - 227
A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib Tadashi KumamotoYuki AokiChitose Ogawa Case Report 25 October 2018 Pages: 228 - 232
Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia Kaito HaradaNoritaka SekiyaKazuteru Ohashi Case Report 05 October 2018 Pages: 233 - 238
The world’s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells Akira AkabayashiEisuke NakazawaNancy S. Jecker Letter to the Editor 07 December 2018 Pages: 239 - 240
Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan Masashi TakiKatsuyuki FukutakeAkira Shirahata Correction 17 December 2018 Pages: 241 - 241
